> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on ADHD Drug Development
- URL: https://www.fdaweb.com/draft-guide-on-adhd-drug-development/
- Published: 2019-05-06T12:00:00.000Z
- Updated: 2026-09-15T01:24:48.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144031

*Federal Register* notice: FDA has made available a draft guidance entitled “Attention Deficit Hyperactivity Disorder (ADHD): Developing Stimulant Drugs for Treatment.” The document is intended to assist sponsors in the clinical development of stimulant drugs for treating ADHD in pediatric and adult patients. It also addresses the agency’s current recommendations regarding the development programs for methylphenidate and amphetamine products, as well as for novel (i.e., new molecular entity) stimulant drugs. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-05-06/pdf/2019-09193.pdf?ref=fdaweb.com).